 Jesse Davidson
Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiopulmonary Bypass | 12 | 2023 | 176 | 6.490 |
Why?
| | Alkaline Phosphatase | 6 | 2019 | 143 | 2.870 |
Why?
| | Cardiac Surgical Procedures | 6 | 2022 | 414 | 2.720 |
Why?
| | Heart Defects, Congenital | 5 | 2023 | 665 | 2.260 |
Why?
| | Postoperative Complications | 8 | 2021 | 2133 | 1.460 |
Why?
| | Acute Kidney Injury | 3 | 2022 | 638 | 1.410 |
Why?
| | Endothelin-1 | 2 | 2022 | 167 | 1.280 |
Why?
| | Heart Arrest | 3 | 2020 | 289 | 1.170 |
Why?
| | Adenosine | 2 | 2018 | 202 | 1.010 |
Why?
| | Kynurenine | 2 | 2021 | 80 | 0.870 |
Why?
| | Infant | 16 | 2022 | 7937 | 0.870 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2023 | 28 | 0.870 |
Why?
| | Tryptophan | 2 | 2022 | 135 | 0.860 |
Why?
| | Swine | 5 | 2023 | 701 | 0.820 |
Why?
| | Oxylipins | 1 | 2022 | 27 | 0.810 |
Why?
| | Fetal Diseases | 1 | 2023 | 147 | 0.800 |
Why?
| | Heart Bypass, Right | 1 | 2022 | 15 | 0.800 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 104 | 0.780 |
Why?
| | Arrhythmias, Cardiac | 2 | 2020 | 279 | 0.740 |
Why?
| | Prospective Studies | 11 | 2022 | 6218 | 0.740 |
Why?
| | Metabolomics | 3 | 2021 | 527 | 0.720 |
Why?
| | Biomarkers | 7 | 2023 | 3418 | 0.690 |
Why?
| | Coronary Care Units | 1 | 2018 | 13 | 0.650 |
Why?
| | Interleukin-1 Receptor-Like 1 Protein | 1 | 2019 | 22 | 0.640 |
Why?
| | Length of Stay | 4 | 2018 | 949 | 0.640 |
Why?
| | Blood Proteins | 1 | 2020 | 233 | 0.630 |
Why?
| | Fontan Procedure | 1 | 2020 | 157 | 0.620 |
Why?
| | Infant, Newborn | 9 | 2023 | 5035 | 0.620 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2019 | 103 | 0.620 |
Why?
| | Endotoxemia | 1 | 2019 | 82 | 0.610 |
Why?
| | Endotoxins | 1 | 2019 | 204 | 0.600 |
Why?
| | Aortic Coarctation | 1 | 2019 | 69 | 0.600 |
Why?
| | 5'-Nucleotidase | 1 | 2018 | 35 | 0.600 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2018 | 474 | 0.560 |
Why?
| | Ventricular Remodeling | 1 | 2019 | 227 | 0.560 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2018 | 176 | 0.550 |
Why?
| | Calcitonin | 2 | 2013 | 23 | 0.540 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 413 | 0.540 |
Why?
| | Postoperative Care | 2 | 2021 | 220 | 0.540 |
Why?
| | Adenosine Monophosphate | 1 | 2016 | 49 | 0.530 |
Why?
| | Protein Precursors | 2 | 2013 | 119 | 0.510 |
Why?
| | Ventricular Function, Left | 1 | 2019 | 468 | 0.510 |
Why?
| | Sepsis | 3 | 2017 | 508 | 0.490 |
Why?
| | Cardiotonic Agents | 2 | 2012 | 119 | 0.480 |
Why?
| | C-Reactive Protein | 2 | 2013 | 362 | 0.460 |
Why?
| | Glipizide | 1 | 2013 | 6 | 0.440 |
Why?
| | Octreotide | 1 | 2013 | 25 | 0.440 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2013 | 30 | 0.440 |
Why?
| | Sulfonylurea Compounds | 1 | 2013 | 44 | 0.430 |
Why?
| | Lung | 2 | 2022 | 3593 | 0.410 |
Why?
| | Treatment Outcome | 8 | 2022 | 9105 | 0.400 |
Why?
| | Cardiac Output, Low | 1 | 2012 | 64 | 0.390 |
Why?
| | Thoracic Surgical Procedures | 1 | 2012 | 56 | 0.390 |
Why?
| | Humans | 26 | 2023 | 114935 | 0.390 |
Why?
| | Purines | 2 | 2022 | 159 | 0.360 |
Why?
| | Vasodilator Agents | 1 | 2012 | 305 | 0.350 |
Why?
| | Kinetics | 3 | 2018 | 1555 | 0.320 |
Why?
| | Hypoglycemia | 1 | 2013 | 386 | 0.320 |
Why?
| | Postoperative Period | 2 | 2022 | 289 | 0.310 |
Why?
| | Metabolome | 2 | 2021 | 283 | 0.310 |
Why?
| | Inflammation | 2 | 2022 | 2485 | 0.300 |
Why?
| | Female | 13 | 2023 | 59580 | 0.280 |
Why?
| | Animals | 7 | 2023 | 31837 | 0.250 |
Why?
| | Critical Care | 2 | 2021 | 474 | 0.250 |
Why?
| | Male | 13 | 2020 | 55663 | 0.250 |
Why?
| | Hypoxia | 2 | 2022 | 960 | 0.240 |
Why?
| | Palliative Care | 2 | 2021 | 640 | 0.240 |
Why?
| | Cohort Studies | 3 | 2023 | 4903 | 0.240 |
Why?
| | Child | 8 | 2022 | 18366 | 0.230 |
Why?
| | Calcitonin Gene-Related Peptide | 2 | 2013 | 31 | 0.210 |
Why?
| | Time Factors | 3 | 2019 | 6125 | 0.210 |
Why?
| | Prostaglandins | 1 | 2022 | 78 | 0.200 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 1 | 2022 | 20 | 0.200 |
Why?
| | Analysis of Variance | 2 | 2016 | 1227 | 0.200 |
Why?
| | Dysbiosis | 1 | 2023 | 146 | 0.190 |
Why?
| | Models, Animal | 1 | 2023 | 346 | 0.190 |
Why?
| | Niacinamide | 1 | 2021 | 64 | 0.180 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 1801 | 0.180 |
Why?
| | Matrix Metalloproteinase 7 | 1 | 2020 | 24 | 0.180 |
Why?
| | Methionine | 1 | 2021 | 144 | 0.180 |
Why?
| | Preoperative Period | 1 | 2020 | 103 | 0.180 |
Why?
| | Heart Function Tests | 1 | 2019 | 58 | 0.170 |
Why?
| | Pulmonary Veins | 1 | 2020 | 85 | 0.170 |
Why?
| | International Classification of Diseases | 1 | 2020 | 117 | 0.170 |
Why?
| | Risk Factors | 4 | 2021 | 8637 | 0.160 |
Why?
| | Child, Preschool | 4 | 2020 | 9086 | 0.160 |
Why?
| | Time | 1 | 2019 | 70 | 0.160 |
Why?
| | Chromatography, Liquid | 1 | 2020 | 348 | 0.160 |
Why?
| | Surgical Procedures, Operative | 1 | 2021 | 206 | 0.160 |
Why?
| | Pilot Projects | 1 | 2023 | 1372 | 0.160 |
Why?
| | Serotonin | 1 | 2020 | 296 | 0.160 |
Why?
| | Matrix Metalloproteinases | 1 | 2019 | 89 | 0.150 |
Why?
| | Rewarming | 1 | 2018 | 16 | 0.150 |
Why?
| | GPI-Linked Proteins | 1 | 2018 | 54 | 0.150 |
Why?
| | Hospital Mortality | 2 | 2018 | 776 | 0.150 |
Why?
| | Mass Spectrometry | 1 | 2020 | 633 | 0.140 |
Why?
| | Respiration, Artificial | 2 | 2018 | 526 | 0.140 |
Why?
| | Heart Ventricles | 1 | 2022 | 711 | 0.140 |
Why?
| | Cardiac Catheterization | 1 | 2020 | 535 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2020 | 3008 | 0.140 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2019 | 360 | 0.130 |
Why?
| | Extracellular Space | 1 | 2016 | 117 | 0.130 |
Why?
| | Solubility | 1 | 2016 | 224 | 0.130 |
Why?
| | Databases, Factual | 1 | 2020 | 1125 | 0.130 |
Why?
| | Kidney | 1 | 2022 | 1184 | 0.130 |
Why?
| | Age Factors | 2 | 2020 | 2891 | 0.120 |
Why?
| | Intensive Care Units, Pediatric | 2 | 2017 | 147 | 0.120 |
Why?
| | Cytokines | 1 | 2023 | 1843 | 0.120 |
Why?
| | Chi-Square Distribution | 1 | 2016 | 495 | 0.120 |
Why?
| | Coronary Thrombosis | 1 | 2015 | 25 | 0.120 |
Why?
| | Proteomics | 1 | 2020 | 844 | 0.120 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2015 | 76 | 0.120 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1440 | 0.110 |
Why?
| | Prognosis | 2 | 2019 | 3344 | 0.110 |
Why?
| | Quality Improvement | 1 | 2021 | 954 | 0.110 |
Why?
| | Cattle | 1 | 2016 | 924 | 0.110 |
Why?
| | Liver Function Tests | 1 | 2013 | 103 | 0.110 |
Why?
| | Algorithms | 1 | 2020 | 1474 | 0.110 |
Why?
| | Intubation | 1 | 2012 | 4 | 0.100 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 387 | 0.100 |
Why?
| | Infusions, Intravenous | 1 | 2013 | 372 | 0.100 |
Why?
| | Logistic Models | 2 | 2020 | 1844 | 0.100 |
Why?
| | Retrospective Studies | 4 | 2021 | 12544 | 0.100 |
Why?
| | Linear Models | 1 | 2013 | 770 | 0.090 |
Why?
| | ROC Curve | 1 | 2012 | 448 | 0.090 |
Why?
| | Intubation, Intratracheal | 1 | 2012 | 215 | 0.090 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2542 | 0.090 |
Why?
| | Risk Assessment | 1 | 2018 | 2975 | 0.080 |
Why?
| | Adolescent | 4 | 2020 | 17829 | 0.080 |
Why?
| | Myocardial Infarction | 1 | 2015 | 929 | 0.080 |
Why?
| | Citalopram | 1 | 2020 | 27 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 48 | 0.040 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 80 | 0.040 |
Why?
| | Adult | 1 | 2020 | 30608 | 0.040 |
Why?
| | Myocardial Contraction | 1 | 2019 | 312 | 0.040 |
Why?
| | Odds Ratio | 1 | 2020 | 954 | 0.040 |
Why?
| | Survival Rate | 1 | 2021 | 1644 | 0.040 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2019 | 218 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2021 | 619 | 0.030 |
Why?
| | Vasoconstrictor Agents | 1 | 2017 | 112 | 0.030 |
Why?
| | Hemodynamics | 1 | 2019 | 1014 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2316 | 0.030 |
Why?
| | Subtilisins | 1 | 1994 | 9 | 0.030 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2015 | 69 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1126 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 1994 | 89 | 0.030 |
Why?
| | Lysosomes | 1 | 1994 | 123 | 0.030 |
Why?
| | Blood Pressure | 1 | 2019 | 1537 | 0.030 |
Why?
| | Endosomes | 1 | 1994 | 124 | 0.030 |
Why?
| | Tissue Plasminogen Activator | 1 | 2015 | 225 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 2015 | 233 | 0.030 |
Why?
| | Membrane Glycoproteins | 1 | 1994 | 429 | 0.030 |
Why?
| | Hospitalization | 1 | 2020 | 1754 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2015 | 400 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3053 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2015 | 1270 | 0.020 |
Why?
| | Young Adult | 1 | 2020 | 10478 | 0.020 |
Why?
| | United States | 1 | 2021 | 12211 | 0.020 |
Why?
| | Immunologic Techniques | 1 | 1994 | 39 | 0.010 |
Why?
| | Furin | 1 | 1994 | 12 | 0.010 |
Why?
| | Cell Compartmentation | 1 | 1994 | 52 | 0.010 |
Why?
| | Cytoplasm | 1 | 1994 | 255 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1994 | 1988 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1994 | 2791 | 0.010 |
Why?
| | Cell Line | 1 | 1994 | 2640 | 0.000 |
Why?
| | Rats | 1 | 1994 | 4963 | 0.000 |
Why?
|
|
Davidson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|